(Q45866168)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Improvements in mucopolysaccharidosis I mice after adult retroviral vector-mediated gene therapy with immunomodulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

main subject

gene therapy

0 references

mucopolysaccharidosis I

1 reference

inferred from title

author

Ramin Sedaghat Herati

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Xiucui Ma

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Yuli Liu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Mindy Tittiger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Anne Hennig

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Attila Kovacs

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Sarah Popelka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Baomei Wang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Mark Bigg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Katherine P Ponder

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

20 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

889-902

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

An update on the frequency of mucopolysaccharide syndromes in British Columbia

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Cord-blood transplants from unrelated donors in patients with Hurler's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Enzyme replacement and enhancement therapies for lysosomal diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Enzyme replacement therapy in feline mucopolysaccharidosis I.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Enzyme-replacement therapy in mucopolysaccharidosis I.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Gene therapy for lysosomal storage diseases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Limited transgene immune response and long-term expression of human alpha-L-iduronidase in young adult mice with mucopolysaccharidosis type I by liver-directed gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Costimulation blockade and its possible future use in clinical transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Adenovirus-mediated gene therapy for mucopolysaccharidosis VII: involvement of cross-correction in wide-spread distribution of the gene products and long-term effects of CTLA-4Ig coexpression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Mucopolysaccharidosis I cats mount a cytotoxic T lymphocyte response after neonatal gene therapy that can be blocked with CTLA4-Ig.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Immunomodulation of transgene responses following naked DNA transfer of human factor VIII into hemophilia A mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Responses against complex antigens in various models of CD4 T-cell deficiency: surprises from an anti-CD4 antibody transgenic mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Successful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis I

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Retinal function is improved in a murine model of a lysosomal storage disease following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Inner ear pathology in the mucopolysaccharidosis VII mouse.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Induction of Immunological Tolerance/Hyporesponsiveness in Baboons with a Nondepleting CD4 Antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Genotoxicity of retroviral integration in hematopoietic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Lipopolysaccharide potentiates the effect of hepatocyte growth factor on hepatocyte replication in rats by augmenting AP-1 activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Infectious tolerance to ADP/ATP carrier peptides induced by anti-L3T4 monoclonal antibody in dilated cardiomyopathy mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Neonatal gene transfer with a retroviral vector results in tolerance to human factor IX in mice and dogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300112

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17311010%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference